BIOGEN INC COMMON (BIIB) Covered Calls

BIOGEN INC COMMON covered calls Biogen Idec Inc. is a global biotechnology Company that creates new standards of care in therapeutic areas with high unmet medical needs.

You can sell covered calls on BIOGEN INC COMMON to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for BIIB (prices last updated Fri 4:16 PM ET):

BIOGEN INC COMMON (BIIB) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
320.41 -9.74 319.95 320.41 1.7M 23 68B
Covered Calls For BIOGEN INC COMMON (BIIB)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 320 13.70 306.71 4.3% 54.1%
Dec 21 320 17.60 302.81 5.7% 32.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Biogen, Inc. is a global biotechnology company, which develops markets and manufactures therapies for people living with neurological, autoimmune and hematologic disorders. Its products include AVONEX, PLEGRIDY, TECFIDERA, TYSABRI, and FAMPYRA for multiple sclerosis, ALPROLIX for hemophilia B and ELOCTATE for hemophilia A. The company also collaborates on the development and commercialization of RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and other conditions and share profits and losses for GAZYVA which is approved for the treatment of chronic lymphocytic leukemia. Biogen was founded on November 12, 2003 and is headquartered in Cambridge, MA.